Contraceptives Market to Reach USD 30.15 Billion by 2027; Usage of Low-dose Combined Oral Contraceptives to Aid Growth: Fortune Business Insights
The global contraceptives market is set to gain traction from the increasing adoption of low-dose combined oral contraceptives (COCs). They include progestogen blended with 20-35 micrograms of ethinylestradiol. This information is given by Fortune Business Insights™ in a new report, titled, “Contraceptives Market Size, Share & COVID-19 Impact Analysis, By Product (Contraceptive Drugs and Contraceptive Devices), By Gender (Male & Female) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channel, Clinics, Public Channel & NGOs, and Others), and Regional Forecast, 2020-2027.” The report further states that the market size was USD 22.49 billion in 2019 and is projected to reach USD 30.15 billion by 2027, exhibiting a CAGR of 5.5% during the forecast period.
The U.N.
Population Fund (UNFPA) mentioned that in the coming months, 7 million
unintended pregnancies are set to occur. Also, approximately 47 million women
belonging to low- and medium-income countries would be unable to use unique contraceptives
owing to the emergence of the COVID-19 pandemic. Besides, a major decline in
the supply and manufacturing of these products worldwide would affect growth
negatively. We are delivering in-depth research reports to help you better
understand the current scenario of the market.
For
more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptives-market-100064
Fortune Business Insights™ lists
out the names of all the renowned producers present in the market. They are as
follows:
•
Pfizer, Inc.
•
Bayer AG
•
Cooper Surgical, Inc.
•
The Female Health Company
•
Teva Pharmaceutical Industries
Limited
•
Merck & Co., Inc.
•
Mayer Laboratories, Inc
•
Church & Dwight, Co., Inc.
•
Medisafe Distribution Inc.
•
Other Players
As the
population is surging worldwide, the governments are taking persistent
initiatives to conduct awareness campaigns for lowering the risks of unwanted
pregnancies, sexual disorders, and abortion. The Government of India, for
instance, committed to deliver family
planning services by the end of 2020 to 48 million new users at the London Summit
on Family Planning. Similarly, the U.S. government developed an infant and a maternal health initiative to promote the usage of
contraceptives effectively. However, contraceptives may cause multiple
side-effects, such as migraine, headaches, and nausea. This factor may hinder
contraceptives market growth.
About
Us:
Fortune Business Insights™ offers expert
corporate analysis and accurate data, helping organizations of all sizes make
timely decisions. We tailor innovative solutions for our clients, assisting
them address challenges distinct to their businesses. Our goal is to empower
our clients with holistic market intelligence, giving a granular overview of
the market they are operating in. Our reports contain a unique mix of tangible
insights and qualitative analysis to help companies achieve sustainable growth.
Our team of experienced analysts and consultants use industry-leading research
tools and techniques to compile comprehensive market studies, interspersed with
relevant data.
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: mailto:sales@fortunebusinessinsights.com
Comments
Post a Comment